Discover 42 paid clinical trials in Evansville, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 42
Active & Responsive
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
for
Migraine
1 location in Evansville
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06417775
Phase3, Recruiting
Active & Responsive
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
for
Endometriosis
1 location in Forest Hill
Sponsor: Aspira Women's Health
Sex: Female
Age: 14 - 50
Code: NCT05245695
Recruiting
Active & Responsive
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
for
Atopic Dermatitis
1 location in Owensboro
Sponsor: Eli Lilly and Company
Sex: All
Age: 12+
Code: NCT07006792
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Get alerts for new trials in your area by subscribing now
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
for
Allergy, Peanut Allergy
1 location in Evansville
Sponsor: DBV Technologies
Sex: All
Age: 1 - 3
Code: NCT07003919
Phase3, Recruiting
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
for
Osteoarthritis Ankle, Post-Traumatic Osteoarthritis of Ankle,
1 location in Evansville
Sponsor: DT MedTech, LLC
Sex: All
Age: 21+
Code: NCT04770870
Recruiting
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
1 location in Evansville
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase3, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
1 location in Evansville
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease